Cargando…
PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations
PLP1 is located on the X-chromosome and encodes myelin proteolipid protein (PLP), the most abundant protein in central nervous system myelin. Generally, point mutations in PLP1 result in X-linked dysmyelinating disorders, such as Pelizaeus-Merzbacher disease (PMD) or spastic paraplegia type 2 (SPG2)...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210135/ https://www.ncbi.nlm.nih.gov/pubmed/30314286 http://dx.doi.org/10.3390/jcm7100342 |
_version_ | 1783367044396220416 |
---|---|
author | Cloake, Nancy C. Yan, Jun Aminian, Atefeh Pender, Michael P. Greer, Judith M. |
author_facet | Cloake, Nancy C. Yan, Jun Aminian, Atefeh Pender, Michael P. Greer, Judith M. |
author_sort | Cloake, Nancy C. |
collection | PubMed |
description | PLP1 is located on the X-chromosome and encodes myelin proteolipid protein (PLP), the most abundant protein in central nervous system myelin. Generally, point mutations in PLP1 result in X-linked dysmyelinating disorders, such as Pelizaeus-Merzbacher disease (PMD) or spastic paraplegia type 2 (SPG2). However, several case studies have identified patients with missense point mutations in PLP1 and clinical symptoms and signs compatible with a diagnosis of multiple sclerosis (MS). To investigate if PLP1 mutations occur relatively frequently in MS, we sequenced the coding regions of PLP1 in 22 female MS patients who had developed disease after the age of 40 and in 42 healthy women, and identified a missense mutation in exon 2 of PLP1 resulting in a Leu30Val mutation in the protein in one of the MS patients. mCherry-tagged plasmids containing wild type or mutant PLP1 sequences of PLP, including two known PMD/SPG2-related mutations as positive controls, were constructed and transfected into Cos-7 cells. In comparison with cells transfected with wild type PLP1, all mutations caused significant accumulation of PLP in the endoplasmic reticulum of the cells and induction of the unfolded protein response—a mechanism that leads to apoptosis of cells expressing mutant proteins. Additionally, in silico analysis of the binding of peptides containing the Leu30Val mutation to the human leukocyte antigen (HLA) molecules carried by the patient harboring this mutation suggested that the mutation could produce several novel immunogenic epitopes in this patient. These results support the idea that mutations in myelin-related genes could contribute to the development of MS in a small proportion of patients. |
format | Online Article Text |
id | pubmed-6210135 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62101352018-11-02 PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations Cloake, Nancy C. Yan, Jun Aminian, Atefeh Pender, Michael P. Greer, Judith M. J Clin Med Article PLP1 is located on the X-chromosome and encodes myelin proteolipid protein (PLP), the most abundant protein in central nervous system myelin. Generally, point mutations in PLP1 result in X-linked dysmyelinating disorders, such as Pelizaeus-Merzbacher disease (PMD) or spastic paraplegia type 2 (SPG2). However, several case studies have identified patients with missense point mutations in PLP1 and clinical symptoms and signs compatible with a diagnosis of multiple sclerosis (MS). To investigate if PLP1 mutations occur relatively frequently in MS, we sequenced the coding regions of PLP1 in 22 female MS patients who had developed disease after the age of 40 and in 42 healthy women, and identified a missense mutation in exon 2 of PLP1 resulting in a Leu30Val mutation in the protein in one of the MS patients. mCherry-tagged plasmids containing wild type or mutant PLP1 sequences of PLP, including two known PMD/SPG2-related mutations as positive controls, were constructed and transfected into Cos-7 cells. In comparison with cells transfected with wild type PLP1, all mutations caused significant accumulation of PLP in the endoplasmic reticulum of the cells and induction of the unfolded protein response—a mechanism that leads to apoptosis of cells expressing mutant proteins. Additionally, in silico analysis of the binding of peptides containing the Leu30Val mutation to the human leukocyte antigen (HLA) molecules carried by the patient harboring this mutation suggested that the mutation could produce several novel immunogenic epitopes in this patient. These results support the idea that mutations in myelin-related genes could contribute to the development of MS in a small proportion of patients. MDPI 2018-10-11 /pmc/articles/PMC6210135/ /pubmed/30314286 http://dx.doi.org/10.3390/jcm7100342 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cloake, Nancy C. Yan, Jun Aminian, Atefeh Pender, Michael P. Greer, Judith M. PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations |
title | PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations |
title_full | PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations |
title_fullStr | PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations |
title_full_unstemmed | PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations |
title_short | PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations |
title_sort | plp1 mutations in patients with multiple sclerosis: identification of a new mutation and potential pathogenicity of the mutations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210135/ https://www.ncbi.nlm.nih.gov/pubmed/30314286 http://dx.doi.org/10.3390/jcm7100342 |
work_keys_str_mv | AT cloakenancyc plp1mutationsinpatientswithmultiplesclerosisidentificationofanewmutationandpotentialpathogenicityofthemutations AT yanjun plp1mutationsinpatientswithmultiplesclerosisidentificationofanewmutationandpotentialpathogenicityofthemutations AT aminianatefeh plp1mutationsinpatientswithmultiplesclerosisidentificationofanewmutationandpotentialpathogenicityofthemutations AT pendermichaelp plp1mutationsinpatientswithmultiplesclerosisidentificationofanewmutationandpotentialpathogenicityofthemutations AT greerjudithm plp1mutationsinpatientswithmultiplesclerosisidentificationofanewmutationandpotentialpathogenicityofthemutations |